SCHEMBL17634280

SCHEMBL17634280

O=C1Nc2ccc(F)cc2NC1c1ccc(C(F)(F)F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.49
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
KIF11 P52732 2/20 0.39
ESR1 P03372 1/20 0.38
HTR7 P34969 2/20 0.37
PARP1 P09874 1/20 0.36
PARP2 Q9UGN5 1/20 0.36
PTPN1 P18031 1/20 0.36
HTR2C P28335 2/20 0.36
TACR1 P25103 2/20 0.35
KCNH2 Q12809 2/20 0.35
PIM1 P11309 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
DDB1 Q16531 1/20 0.35
CRBN Q96SW2 1/20 0.35
CYP11B2 P19099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17634318 0.94 TDP1 (0.49) TDP1KMT2AMEN1KIF11ESR1
SCHEMBL17634186 0.85 CYP1A2 (0.40) TDP1KMT2AMEN1KIF11ESR1
SCHEMBL17634287 0.82 PARP1 (0.48) TDP1KMT2AMEN1ESR1PARP1
SCHEMBL17634185 0.80 CYP1A2 (0.40) TDP1KMT2AMEN1KIF11ESR1
SCHEMBL30991569 0.80 TDP1 (0.48) TDP1KMT2AMEN1HTR7ALDH1A1
SCHEMBL17634152 0.74 MEN1 (0.43) TDP1KMT2AMEN1KIF11ESR1
SCHEMBL17634136 0.74 KMT2A (0.43) TDP1KMT2AMEN1KIF11ESR1
SCHEMBL17634116 0.73 PARP1 (0.51) KMT2AMEN1KIF11PARP1PARP2
SCHEMBL17634231 0.73 BRD4 (0.47) KMT2A
SCHEMBL17634285 0.73 BRD4 (0.40) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197900-B1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME (US) 2020-02-12 EP disclosed
US-9969752-B2 Inhibitors of HIF prolyl hydroxylase MERCK SHARP & DOHME CORP. (US) 2018-05-15 US disclosed
US-20170233412-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME CORP. (US) 2017-08-17 US disclosed
EP-3197900-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE Merck Sharp & Dohme Corp. (US) 2017-08-02 EP disclosed
WO-2016049099-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE MERCK SHARP & DOHME CORP. (US) 2016-03-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170233412-A1 INHIBITORS OF HIF PROLYL HYDROXYLASE HIF1AN, HIF1A, EGLN2 TDP1 4620/4885KMT2A 940/4885MEN1 4300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.